Nuveen, LLC Taysha Gene Therapies, Inc. Transaction History
Nuveen, LLC
- $315 Billion
- Q1 2025
A detailed history of Nuveen, LLC transactions in Taysha Gene Therapies, Inc. stock. As of the latest transaction made, Nuveen, LLC holds 546,414 shares of TSHA stock, worth $1.23 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
546,414Holding current value
$1.23 Million% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TSHA
# of Institutions
128Shares Held
149MCall Options Held
48KPut Options Held
7.8K-
Avoro Capital Advisors LLC New York, NY20MShares$45 Million0.5% of portfolio
-
Morgan Stanley New York, NY17.6MShares$39.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$26.4 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA10.9MShares$24.5 Million0.3% of portfolio
-
Octagon Capital Advisors LP New York, NY10.5MShares$23.5 Million4.03% of portfolio
About Taysha Gene Therapies, Inc.
- Ticker TSHA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,359,500
- Market Cap $109M
- Description
- Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for th...